A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis

NCT00380744 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: LY2189102
DRUG: placebo

Sponsor

Eli Lilly and Company